Literature DB >> 15351781

Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions.

Oleg G Kisselev1, Maureen A Downs, J Hugh McDowell, Paul A Hargrave.   

Abstract

Phosphorylation of activated G-protein-coupled receptors and the subsequent binding of arrestin mark major molecular events of homologous desensitization. In the visual system, interactions between arrestin and the phosphorylated rhodopsin are pivotal for proper termination of visual signals. By using high resolution proton nuclear magnetic resonance spectroscopy of the phosphorylated C terminus of rhodopsin, represented by a synthetic 7-phosphopolypeptide, we show that the arrestin-bound conformation is a well ordered helix-loop structure connected to rhodopsin via a flexible linker. In a model of the rhodopsin-arrestin complex, the phosphates point in the direction of arrestin and form a continuous negatively charged surface, which is stabilized by a number of positively charged lysine and arginine residues of arrestin. Opposite to the mostly extended structure of the unphosphorylated C-terminal domain of rhodopsin, the arrestin-bound C-terminal helix is a compact domain that occupies a central position between the cytoplasmic loops and occludes the key binding sites of transducin. In conjunction with other binding sites, the helix-loop structure provides a mechanism of shielding phosphates in the center of the rhodopsin-arrestin complex and appears critical in guiding arrestin for high affinity binding with rhodopsin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351781     DOI: 10.1074/jbc.M407341200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Bacteriorhodopsin chimeras containing the third cytoplasmic loop of bovine rhodopsin activate transducin for GTP/GDP exchange.

Authors:  Andrew H Geiser; Michael K Sievert; Lian-Wang Guo; Jennifer E Grant; Mark P Krebs; Dimitrios Fotiadis; Andreas Engel; Arnold E Ruoho
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

Review 2.  G protein-coupled receptor rhodopsin.

Authors:  Krzysztof Palczewski
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Interaction of a fragment of the cannabinoid CB1 receptor C-terminus with arrestin-2.

Authors:  Kunal Bakshi; Richard W Mercier; Spiro Pavlopoulos
Journal:  FEBS Lett       Date:  2007-09-24       Impact factor: 4.124

4.  Lipids Alter Rhodopsin Function via Ligand-like and Solvent-like Interactions.

Authors:  Leslie A Salas-Estrada; Nicholas Leioatts; Tod D Romo; Alan Grossfield
Journal:  Biophys J       Date:  2018-01-23       Impact factor: 4.033

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

6.  The cytoplasmic tail of rhodopsin triggers rapid rod degeneration in kinesin-2 mutants.

Authors:  Dong Feng; Zhe Chen; Kuang Yang; Shanshan Miao; Bolin Xu; Yunsi Kang; Haibo Xie; Chengtian Zhao
Journal:  J Biol Chem       Date:  2017-08-30       Impact factor: 5.157

Review 7.  The cytoplasmic rhodopsin-protein interface: potential for drug discovery.

Authors:  Naveena Yanamala; Eric Gardner; Alec Riciutti; Judith Klein-Seetharaman
Journal:  Curr Drug Targets       Date:  2012-01       Impact factor: 3.465

8.  Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2.

Authors:  Shubhadra N Singh; Kunal Bakshi; Richard W Mercier; Alexandros Makriyannis; Spiro Pavlopoulos
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

9.  Isotope labeling of mammalian GPCRs in HEK293 cells and characterization of the C-terminus of bovine rhodopsin by high resolution liquid NMR spectroscopy.

Authors:  Karla Werner; Christian Richter; Judith Klein-Seetharaman; Harald Schwalbe
Journal:  J Biomol NMR       Date:  2007-11-13       Impact factor: 2.835

10.  Arrestin binds to different phosphorylated regions of the thyrotropin-releasing hormone receptor with distinct functional consequences.

Authors:  Brian W Jones; Patricia M Hinkle
Journal:  Mol Pharmacol       Date:  2008-04-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.